Delwinds Insurance Acquisition Corp. Completes Business Combination with FOXO Technologies

September 16, 2022

FOXO Technologies Inc., a longevity-focused epigenetics and AI platform for the life insurance industry, completed a business combination with SPAC Delwinds Insurance Acquisition Corp., resulting in FOXO listing on the NYSE American under the ticker FOXO. The transaction positions FOXO to commercialize its molecular biomarkers and saliva-based underwriting protocols and to scale its FOXO Longevity Report and MGA distribution relationships.

Buyers
Delwinds Insurance Acquisition Corp.
Targets
FOXO Technologies Inc.
Industry
Biotechnology
Location
Minnesota, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.